Comparison of Concomitant Mesalamine and Immunomodulator Therapy and Immunomodulator Monotherapy for Crohn's Disease

BACKGROUND: Although immunomodulators are increasingly used in Crohn's disease (CD), a significant number of gastroenterologists still use 5-aminosalicylate (5-ASA) in combination with azathioprine (AZA) or 6-mercaptopurine (6-MP); there is limited evidence regarding the benefit of concomitant...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwak, Min Seob, Kim, Kyung-Jo, Cheon, Jae Hee, Kim, Wan Soo, Lee, Jeong-Mi, Hwang, Sung Wook, Park, Sang Hyoung, Yang, Dong-Hoon, Ye, Byong Duk, Byeon, Jeong-Sik, Myung, Seung-Jae, Yang, Suk-Kyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822780/
https://www.ncbi.nlm.nih.gov/pubmed/29576767
http://dx.doi.org/10.1155/2018/4826973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822780/
https://www.ncbi.nlm.nih.gov/pubmed/29576767
http://dx.doi.org/10.1155/2018/4826973

Ejemplares similares